Present and future role of FDG-PET/CT imaging in the management of breast cancer |
| |
| Authors: | Kazuhiro Kitajima Yasuo Miyoshi |
| |
| Institution: | 1.Department of Nuclear Medicine and PET Center,Hyogo College of Medicine,Nishinomiya,Japan;2.Department of Breast and Endocrine Surgery,Hyogo College of Medicine,Nishinomiya,Japan |
| |
| Abstract: | Integrated positron emission tomography/computed tomography (PET/CT) with 2-18F]fluoro-2-deoxy-d-glucose (FDG) is a useful tool for acquisition of both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session, and has opened a new field in clinical oncologic imaging. FDG-PET/CT has been used successfully for the diagnosis, initial staging, restaging, early treatment response assessment, evaluation of metastatic disease response, and prognostication of breast cancer as well as various malignant tumors. We herein review the current place and role of FDG-PET/CT in the management of breast cancer, focusing on its usefulness and limitations in the imaging of these patients. |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
